<?xml version="1.0" encoding="UTF-8"?>
<p>In addition to the hypomethylation of the Î±-synuclein gene, the epigenetic regulation of other genes associated with DLB has been proposed, including ataxin 2 (ATXN2), deglycase PARK7 and parkin (PRKN) [
 <xref rid="B24-biomolecules-11-00624" ref-type="bibr">24</xref>]. Furthermore, changes in H3 histone acetylation might also contribute to LBD development [
 <xref rid="B24-biomolecules-11-00624" ref-type="bibr">24</xref>]. Since epigenetic modifications in DLB patients are reversible and dynamic, they are used as appropriate targets for DLB treatment.
</p>
